Literature DB >> 20609806

Abdominal pain and severe hyponatremia after lung cancer surgery.

Jean-Baptiste Stern1, Julie Cosserat, Christiane Strauss, Philippe Girard, Dominique Gossot, Rafaelle Caliandro, Pierre Magdeleinat.   

Abstract

We report a 54-year-old man who presented with abdominal pain and severe hyponatremia a few days after a left lower lobectomy for lung cancer. An abdominal computed tomography scan without contrast showed a bilateral adrenal hemorrhagic infarction, mainly on the right side. Serum sodium level was 113 mmol/L, and cortisol level was 0 microg/L. Anticardiolipin-type antibodies (immunoglobulin G isotype) level was 75 GPL/mL (normal value < 10). With hydrocortisone supplementation and curative doses of low-molecular-weight heparin, the patient recovered progressively and was discharged on postoperative day 17. Final diagnosis was bilateral adrenal gland hemorrhagic necrosis leading to adrenal insufficiency, associated with antiphospholipid syndrome. We discuss the mechanism and the role of the operation in the occurrence of this particularly rare and potentially life-threatening complication. Recommendations to prevent thrombosis in surgical patients who have antiphospholipid antibodies are lacking. Copyright 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20609806     DOI: 10.1016/j.athoracsur.2009.12.027

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Adrenal Insufficiency Due to Bilateral Adrenal Non-Hodgkin's Lymphoma: A Case Report.

Authors:  Fahed S Bangash
Journal:  Cureus       Date:  2020-03-22

2.  Adrenal Insufficiency in Metastatic Lung Cancer.

Authors:  Filipe Carvalho; Fernanda Louro; Raed Zakout
Journal:  World J Oncol       Date:  2015-06-12

3.  Adrenal failure and antiphospholipid syndrome.

Authors:  Katarina Mlekuš Kozamernik; Mojca Jensterle; Aleš Ambrožič; Marija Pfeifer
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.